What Is Immunodeficiency Infusion Therapy
Immunodeficiency infusion therapy is the cornerstone of treatment for patients living with primary and secondary immune deficiency disorders — conditions in which the immune system is unable to produce sufficient antibodies to protect the body against infections and disease.
KabaFusion is one of the nation’s most trusted providers of immunodeficiency infusion therapy — delivering expert IVIG and SCIG treatment to patients in the comfort and safety of their own homes with the highest standard of clinical care available anywhere in the United States.
Understanding Immunodeficiency Disorders
Immunodeficiency disorders are conditions in which the immune system’s ability to function normally is impaired. This impairment can result from a genetic defect — known as primary immunodeficiency — or from another medical condition, treatment, or environmental factor — known as secondary immunodeficiency.
Primary immunodeficiency diseases represent a group of more than 450 rare chronic disorders in which part of the body’s immune system is missing or does not function normally. The most common primary immunodeficiency diseases include Common Variable Immunodeficiency — CVID. X-Linked Agammaglobulinemia — XLA. Specific Antibody Deficiency. Hyper IgM Syndrome.
Each of these conditions creates a specific pattern of immune system failure that immunodeficiency infusion therapy is designed to address — replacing the missing or deficient immunoglobulins that the patient’s immune system cannot produce independently.
Immunodeficiency Conditions Treated at KabaFusion
KabaFusion’s immunodeficiency infusion therapy programme covers a comprehensive range of primary and secondary immune deficiency conditions. Every patient referred to KabaFusion receives a personalised immunodeficiency infusion care plan developed in close collaboration with their treating immunologist.
Conditions treated through KabaFusion’s trusted immunodeficiency infusion programme include Common Variable Immunodeficiency — CVID. X-Linked Agammaglobulinemia — XLA. Specific Antibody Deficiency — SAD. Hyper IgM Syndrome. Selective IgA Deficiency with recurrent infections. Secondary immunodeficiency due to hematologic malignancies. Secondary immunodeficiency related to immunosuppressive therapy. Good Syndrome — immunodeficiency with thymoma.
If your immunologist has recommended immunodeficiency infusion therapy for any of these conditions, KabaFusion’s trusted home care programme is ready to support your treatment journey from day one.
IVIG Therapy for Immunodeficiency Infusion — How It Works
IVIG therapy is the established standard of care for most primary immunodeficiency diseases and the clinical foundation of KabaFusion’s immunodeficiency infusion programme. IVIG delivers the missing immunoglobulins — antibodies — that a patient’s immune system cannot produce independently, reducing the frequency and severity of infections and restoring health and quality of life.
IVIG is administered intravenously over several hours — typically every 3 to 4 weeks — based on the patient’s IgG levels, clinical condition, and physician recommendations. KabaFusion works with each patient’s immunologist to select the most appropriate IVIG product and dose for their specific immunodeficiency infusion requirements.
KabaFusion’s clinical pharmacists bring trusted specialist expertise to every immunodeficiency infusion programme — carefully calibrating IVIG dosing, managing infusion rate titration, and coordinating every aspect of therapy delivery to ensure optimal outcomes and patient safety throughout the immunodeficiency infusion process.
SCIG Therapy — A Trusted Flexible Alternative for Immunodeficiency Infusion
Subcutaneous immunoglobulin — SCIG — therapy is an increasingly trusted alternative to IVIG for immunodeficient patients who prefer greater flexibility and independence in managing their immunodeficiency infusion schedule.
SCIG therapy is administered through a small needle placed just under the skin — typically once a week or more frequently in smaller doses. Many patients choose SCIG because it produces more stable serum IgG levels, requires shorter infusion times, and can be self-administered at home once training is complete.
KabaFusion provides comprehensive SCIG training, all required supplies, and ongoing clinical oversight for immunodeficiency infusion patients making the transition to subcutaneous therapy. Our trusted nursing team works closely with each patient to ensure they are fully confident and comfortable with self-administration before transitioning to independent SCIG immunodeficiency infusion therapy at home.
Clinical Excellence in Trusted Immunodeficiency Infusion at KabaFusion
KabaFusion’s trusted reputation in immunodeficiency infusion therapy is built on clinical excellence and a genuine commitment to patient outcomes that consistently sets it apart from general home infusion providers across the country.
Our pharmacists and nurses receive dedicated training in the specific requirements of immunoglobulin therapy — including rate titration, premedication protocols, and the recognition and management of adverse reactions unique to immunodeficiency infusion patients.
KabaFusion maintains meticulous records of each patient’s infusion history, IgG trough levels, infection frequency, and clinical response — sharing this data regularly with the treating immunologist to support ongoing immunodeficiency infusion treatment optimisation. This proactive and trusted approach to physician communication ensures that every patient’s immunodeficiency infusion programme remains precisely calibrated to their evolving clinical needs at every stage of their treatment.
Access and Insurance Coverage for Immunodeficiency Infusion Therapy
KabaFusion accepts Medicare, Medicaid, and most commercial insurance plans for immunodeficiency infusion therapy. Our trusted benefits specialists work diligently to secure and maintain coverage for every immunodeficiency infusion patient — handling prior authorisations, medical necessity documentation, and insurance appeals on behalf of each patient without exception.
KabaFusion also connects immunodeficiency infusion patients with manufacturer patient assistance programmes when needed — ensuring that no patient is denied access to the trusted immunodeficiency infusion therapy they need due to financial barriers.
Contact KabaFusion for Trusted Immunodeficiency Infusion Today
KabaFusion is a nationally recognised leader in trusted home-based immunodeficiency infusion therapy. Our specialist clinical team delivers personalised IVIG and SCIG immunodeficiency infusion treatment for primary and secondary immune deficiency conditions — with 24/7 clinical support and an unwavering commitment to patient-centred care across all 50 states.
Phone: 888.204.9304 Website: www.kabafusion.com Email: info@KabaFusion.com Quick Referral: kabafusion.com/easy-patient-referral-form
